cinacalcet has been researched along with Hypertrophy, Left Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayés, B; Bonet, J; Casals, M; Fernández-Crespo, P; López-Ayerbe, J; Romero, R | 1 |
| Hu, B; Hu, P; Lu, L; Qin, YH; Wang, J; Xuan, Q | 1 |
1 review(s) available for cinacalcet and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease.
Topics: Animals; Calcimimetic Agents; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Diet; Endothelium, Vascular; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Kidney Transplantation; Male; Naphthalenes; Parathyroid Hormone; Phosphates; Polyamines; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification; Vitamin D; Vitamin D Deficiency | 2012 |
1 other study(ies) available for cinacalcet and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Cinacalcet may reduce arterial stiffness in patients with chronic renal disease and secondary hyperparathyroidism - results of a small-scale, prospective, observational study.
Topics: Adult; Aged; Alkaline Phosphatase; Aorta; Aortic Diseases; Biomarkers; Blood Pressure; Calcimimetic Agents; Calcium; Cinacalcet; Elasticity; Female; Humans; Hyperparathyroidism, Secondary; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Prospective Studies; Pulsatile Flow; Renal Dialysis; Spain; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2011 |